Jaguar Health, Inc. (JAGX)
0.8433
-0.03
(-3.07%)
USD |
NASDAQ |
Feb 26, 16:00
0.8433
0.00 (0.00%)
After-Hours: 18:50
Jaguar Health Research and Development Expense (Quarterly) : 3.658M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 2.436M |
| Geron Corp. | 15.83M |
| Corvus Pharmaceuticals, Inc. | 8.454M |
| Rapt Therapeutics, Inc. | 12.03M |
| Recursion Pharmaceuticals, Inc. | 83.34M |